Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is a biotechnology company. The company discovers, develops, manufactures, and commercializes small molecule drugs for patients with serious diseases. The firm solutions treat cystic fibrosis, infectious diseases, and autoimmune diseases.
VRTX
Vertex Pharmaceuticals Inc
NASDAQ
420.58
USD
0.78%
+3.26
OPEN
419.48
PREV CLOSE
417.32
DAY RANGE
420.67 - 415.06
VOLUME
168.8K
AVG. VOLUME
896.4K
52 WEEK RANGE
448.40 - 309.43
Buy VRTX stocks now with Interactive Brokers – the most advanced investment platform
Valuations metrics
Market capitalization
107.8B
Enterprise value
97.4B
Trailing pe
30.044636
Forward pe
22.742235
Peg ratio
22.742235
Price to sales ttm
10.922576
Price to book mrq
6.1170883
Enterprise to revenue
9.868
Enterprise to ebitda
21.753
Financials
Fiscal year ends
2023-12-31
Most recent quarter
2023-12-31
Profit margin
0.36676
Operating margin
0.37971002
Return on assets ttm
0.13171
Return on equity ttm
0.22986999
Income statement
Revenue ttm
9.9B
Revenue per share ttm
38.297
Quarterly revenue growth
0.093
Gross profit ttm
8.6B
Ebitda
5.1B
Net income to common ttm
3.6B
Diluted eps ttm
13.89
Quarterly earnings growth yoy
0.183
Balance sheet
Total cash mrq
11.2B
Total cash per share mrq
43.43
Total debt mrq
808.4M
Total debt to equity mrq
4.598
Current ratio mrq
3.987
Book value per share mrq
68.222
Cash flow
Operating cash flow ttm
3.5B
Levered free cash flow ttm
3.5B
Stock statistics
Shares outstanding
258.3M
Float shares
257.4M
Avg 10 volume
1M
Avg 90 volume
1M
Shares short
4.1M
Short ratio
2.57
Short percent of shares outstanding
0.015700001
Percent held by insiders
0.0010800001
Percent held by institutions
0.95783997
Stock price summary
Fifty two week low
310.9
Fifty two week high
448.4
Fifty two week change
25.758
Beta
0.351
Day 50 ma
423.0006
Day 200 ma
377.61404
Dividends and splits
Last split factor
2-for-1 split
Last split date
2000-08-24